ER + HER2- early-stage breast cancer: association of HER2 expression, tumor characteristics, and outcomes
- Hadar Goldvaser
- , Rinat Yerushalmi
- , Raz Mutai
- , Iryna Kuchuk
- , Margarita Toker
- , Shani Paluch-Shimon
- , Karen Drumea
- , Ella Evron
- , Amir Sonnenblick
- , Einav Gal-Yam
- , Gil Bar Sela
- , Ayelet Shai
- , Rotem Merose
- , Avital Bareket-Samish
- , Lior Soussan-Gutman
- , Salomon M. Stemmer
- Memorial Sloan-Kettering Cancer Center
- Rabin Medical Center Israel
- Tel Aviv University
- Soroka Medical Center
- Ben-Gurion University of the Negev
- Hadassah University Medical Centre
- Hebrew University of Jerusalem
- Lin Medical Center
- Technion-Israel Institute of Technology
- Kaplan Medical Center Israel
- Tel Aviv Sourasky Medical Center
- Sheba Medical Center at Tel Hashomer
- Emek Medical Center
- Assaf Harofeh Medical Center
- BioInsight Ltd
- Oncotest-Rhenium
Research output: Contribution to journal › Article › peer-review